Ratings CLIO Cosmetics Co.,Ltd

Equities

End-of-day quote Korea S.E. Other stock markets 23:00:00 13/05/2024 BST			5-day change	1st Jan Change
36,850 ^KRW	+1.80%		+7.91%	+19.64%

04-19	CLIO Cosmetics Co.,Ltd agreed to acquire Doowon for KRW 7.05 billion.	CI
03-21	CLIO Cosmetics Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	CI

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
The company presents an interesting fundamental situation from a short-term investment perspective.

Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 54% by 2026.
Thanks to a sound financial situation, the firm has significant leeway for investment.
Over the past year, analysts have regularly revised upwards their sales forecast for the company.
Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.

The company is not the most generous with respect to shareholders' compensation.
The average consensus view of analysts covering the stock has deteriorated over the past four months.
The company's earnings releases usually do not meet expectations.

	1st Jan change	Capi.	ESG Refinitiv
CLIO COSMETICS CO.,LTD	+19.64%	477M	-
L'ORÉAL	+0.83%	265B	B-
KAO CORPORATION	+20.31%	20.59B	B+
SHISEIDO COMPANY, LIMITED	+14.35%	12.22B	A-
COTY INC.	-11.84%	9.42B	A-
AMOREPACIFIC CORPORATION	+16.55%	7.67B	B+
PROYA COSMETICS CO.,LTD.	+11.43%	6.05B	B
NATURA &CO HOLDING S.A.	-3.55%	4.45B	B+
INTER PARFUMS, INC.	-13.42%	3.98B	C-
INTERPARFUMS	-4.17%	3.66B	B-

Investor Rating

Trading Rating

ESG Refinitiv

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality